| 000 | 01770 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515053935.0 | ||
| 264 | 0 | _c20070409 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.4161/cc.6.1.3699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatthews, David J | |
| 245 | 0 | 0 |
_aPharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _cJan 2007 |
||
| 300 |
_a104-10 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCheckpoint Kinase 1 |
| 650 | 0 | 4 | _aCheckpoint Kinase 2 |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, cdc _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aS Phase _xdrug effects |
| 650 | 0 | 4 |
_aXenograft Model Antitumor Assays _xmethods |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aYakes, F Michael | |
| 700 | 1 | _aChen, Jason | |
| 700 | 1 | _aTadano, Michele | |
| 700 | 1 | _aBornheim, Lester | |
| 700 | 1 | _aClary, Douglas O | |
| 700 | 1 | _aTai, Albert | |
| 700 | 1 | _aWagner, Jill M | |
| 700 | 1 | _aMiller, Nicole | |
| 700 | 1 | _aKim, Yong D | |
| 700 | 1 | _aRobertson, Scott | |
| 700 | 1 | _aMurray, Louis | |
| 700 | 1 | _aKarnitz, Larry M | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 6 _gno. 1 _gp. 104-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.6.1.3699 _zAvailable from publisher's website |
| 999 |
_c16808343 _d16808343 |
||